4.7 Article

UVB Exposure Prevents Atherosclerosis by Regulating Immunoinflammatory Responses

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.116.308063

Keywords

atherosclerosis; immunology; inflammation; lymphocytes; ultraviolet rays

Funding

  1. JSPS [23790849, 25860601, 24591114]
  2. Japan Heart Foundation
  3. Astellas/Pfizer Grant for Research on Atherosclerosis Update
  4. Kimura Memorial Heart Foundation
  5. Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology
  6. Global Center of Excellence
  7. Banyu Life Science Foundation International
  8. Suzuken Memorial Foundation
  9. ONO Medical Research Foundation
  10. Takeda Scientific Foundation
  11. Senshin Medical Research Foundation
  12. Mitsui Life Social Welfare Foundation
  13. Yakult Bioscience Research Foundation
  14. Uehara Memorial Foundation
  15. Japan Circulation Society Translational Research Foundation
  16. Grants-in-Aid for Scientific Research [15K08530, 23790849, 25860601, 16H06295, 24591114] Funding Source: KAKEN

Ask authors/readers for more resources

Objective-UVB irradiation is an established treatment for immunoinflammatory cutaneous disorders and has been shown to suppress cutaneous and systemic inflammatory diseases through modulation of the adaptive immune response. However, it remains unknown whether UVB irradiation prevents an immunoinflammatory disease of arteries such as atherosclerosis. Approach and Results-Here, we show that UVB exposure inhibits the development and progression of atherosclerosis in atherosclerosis-prone mice by expanding and enhancing the functional capacity of CD4(+) forkhead box P3(+) regulatory T cells and regulating proatherogenic T-cell responses. Experimental studies in Langerhans cell-depleted mice revealed that epidermal Langerhans cells play a critical role in UVB-dependent induction of CD4(+) forkhead box P3(+) regulatory T cells, suppression of proatherogenic T-cell responses, and prevention of atherosclerotic plaque development. Conclusions-Our findings suggest the skin immune system as a novel therapeutic target for atherosclerosis and provide a novel strategy for the treatment and prevention of atherosclerosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available